Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 3/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9004261 | 0.87 | HDAC4 (0.42) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL28465330 | 0.87 | SLC6A2 (0.44) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL944385 | 0.85 | SLC6A2 (0.41) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL4379605 | 0.84 | SLC6A2 (0.42) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL11041604 | 0.82 | SLC6A2 (0.40) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL28601598 | 0.82 | SLC6A2 (0.43) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL9797247 | 0.82 | HDAC4 (0.48) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL3483657 | 0.82 | SLC6A2 (0.40) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL28576602 | 0.81 | SLC6A2 (0.40) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL58980 | 0.81 | SLC6A2 (0.62) | SLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130126805-A1 | Method For Producing Alkylphosphonous Acid Salts | CLARIANT FINANCE (BVI) LIMITED (VG) | 2013-05-23 | — | — | US | disclosed |
| EP-2563798-A2 | METHOD FOR PRODUCING ALKYLPHOSPHONOUS ACID SALTS | Clariant Finance (BVI) Limited (VG) | 2013-03-06 | — | — | EP | disclosed |
| WO-2011134621-A2 | METHOD FOR PRODUCING ALKYLPHOSPHONOUS ACID SALTS | CLARIANT INTERNATIONAL LTD (CH) | 2011-11-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130126805-A1 | Method For Producing Alkylphosphonous Acid Salts | AGPAT2, AGPAT5, POF1B | SLC6A2 1062/4885SLC6A4 1436/4885SLC6A3 1375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.